Biotech/Pharma Stocks To Watch In The First Days Of February
The final week of January was yet another big one for biotech, with perhaps the most important development of the week being phase III trial results for Novavax’s COVID-19 vaccine.
The final week of January was yet another big one for biotech, with perhaps the most important development of the week being phase III trial results for Novavax’s COVID-19 vaccine.
The genomic revolution in underway, with the author of today’s article noting that “artificial intelligence is converging with decades of breakthrough genomics research to create a new generation of hyper-efficient, hyper-accurate, and hyper-precise gene editing medicines.”
As January comes to a close, which biotech stocks await FDA decisions in February that could serve as catalysts?
When it comes to the performance of healthcare companies during the pandemic, the author of today’s article notes that “Those best prepared for developing a… Read More »This Biotech Laggard Could Offer Traders A Market-Beating Opportunity
“Investors who want the massive potential gains from penny stock investing should focus on those with a real business producing real cash,” advise the authors… Read More »“Real Businesses Producing Real Cash”: 3 Penny Stocks Poised To Benefit From Major Market Trends
Over the course of the past 12 months, Novavax has gone from penny stock status before the pandemic to skyrocketing more than 2,700% over the course of the pandemic thus far.
Four biotech penny stocks with upside to analyst price targets ranging from 42% to 291%.
or these five stocks – which include a smaller cap mining company and a small-cap biotech play focused on developing specialty products for underserved patient populations read more!
The author of today’s article notes that high-profile IPOs typically follow a pattern – and given this pattern, he is bullish on “a biotech stock that went public just under a month ago with a story that perfectly fits the times, and whose stock has followed exactly that pattern.”
2020 Top Stock Picker shares insights on the outlook for genomics, electric vehicles, blockchain technology and more.